Deutsche Bank Aktiengesellschaft Upgrades Acadia Healthcare (NASDAQ:ACHC) to "Buy"

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) was upgraded by equities research analysts at Deutsche Bank Aktiengesellschaft from a "hold" rating to a "buy" rating in a note issued to investors on Thursday, Marketbeat.com reports. The brokerage currently has a $75.00 price objective on the stock, up from their prior price objective of $45.00. Deutsche Bank Aktiengesellschaft's price objective indicates a potential upside of 85.92% from the stock's previous close.

A number of other analysts have also recently weighed in on ACHC. StockNews.com cut shares of Acadia Healthcare from a "hold" rating to a "sell" rating in a research note on Friday, November 22nd. Royal Bank of Canada dropped their target price on Acadia Healthcare from $94.00 to $64.00 and set an "outperform" rating for the company in a report on Monday, November 18th. Barclays lowered their price target on Acadia Healthcare from $76.00 to $43.00 and set an "overweight" rating on the stock in a research report on Friday, November 22nd. KeyCorp initiated coverage on shares of Acadia Healthcare in a research note on Friday, October 11th. They issued a "sector weight" rating on the stock. Finally, Cantor Fitzgerald reiterated a "neutral" rating and set a $52.00 target price on shares of Acadia Healthcare in a research report on Tuesday. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, Acadia Healthcare currently has a consensus rating of "Moderate Buy" and a consensus target price of $75.44.

Acadia Healthcare Stock Performance

ACHC traded up $0.50 on Thursday, hitting $40.34. 1,831,986 shares of the stock traded hands, compared to its average volume of 1,039,677. The business has a fifty day moving average price of $46.02 and a two-hundred day moving average price of $62.13. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare has a 52 week low of $36.50 and a 52 week high of $87.77. The firm has a market capitalization of $3.75 billion, a PE ratio of 13.83, a P/E/G ratio of 1.82 and a beta of 1.29.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $0.91 EPS for the quarter, topping the consensus estimate of $0.90 by $0.01. The firm had revenue of $815.60 million during the quarter, compared to analysts' expectations of $819.42 million. Acadia Healthcare had a return on equity of 11.12% and a net margin of 8.99%. Acadia Healthcare's quarterly revenue was up 8.7% compared to the same quarter last year. During the same period last year, the business earned $0.91 earnings per share. On average, research analysts predict that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Institutional Trading of Acadia Healthcare

Several hedge funds have recently modified their holdings of ACHC. Blue Trust Inc. raised its position in Acadia Healthcare by 86.1% in the 2nd quarter. Blue Trust Inc. now owns 536 shares of the company's stock worth $36,000 after purchasing an additional 248 shares during the last quarter. GAMMA Investing LLC boosted its holdings in Acadia Healthcare by 57.1% in the third quarter. GAMMA Investing LLC now owns 663 shares of the company's stock valued at $42,000 after acquiring an additional 241 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new stake in Acadia Healthcare during the 2nd quarter worth about $59,000. Covestor Ltd lifted its position in Acadia Healthcare by 834.4% during the 3rd quarter. Covestor Ltd now owns 1,140 shares of the company's stock valued at $72,000 after purchasing an additional 1,018 shares during the period. Finally, DekaBank Deutsche Girozentrale bought a new position in shares of Acadia Healthcare in the 3rd quarter valued at about $86,000.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.